Literature DB >> 9023733

Differential expression of NGFI-B and RNR-1 genes in various tissues and developing brain of the rat: comparative study by quantitative reverse transcription-polymerase chain reaction.

S Bandoh1, T Tsukada, K Maruyama, N Ohkura, K Yamaguchi.   

Abstract

NGFI-B and RNR-1 are closely related transcription factors that constitute a distinct subclass within the steroid/thyroid hormone receptor superfamily. They have been implicated in neuronal differentiation, neuroendocrine regulation of adrenocortical function and T-cell apoptosis. In this study, we measured and compared NGFI-B and RNR-1 mRNA levels in various adult rat tissues and in the developing rat brain by means of the quantitative reverse transcription-polymerase chain reaction. The use of RNA standards synthesized in vitro allowed direct comparison of the amount of the transcripts of these two genes. We demonstrated that the transcripts of both genes were present in all tissues examined although the expression levels widely varied. We found the highest constitutive expression of both genes in the pituitary. High levels of NGFI-B were also expressed in the cerebral cortex, muscle, ventral prostate, thymus and adrenal glands, whereas high levels of RNR-1 expression were restricted to the pituitary and cerebral cortex. These findings were consistent with the notion that NGFI-B and RNR-1 are involved in various signal transduction systems in diverse cell types. The amount of NGFI-B mRNA was greater than that of RNR-1 mRNA in all adult rat tissues, with the highest ratio of NGFI-B relative to RNR-1 expression in the muscle and leukocytes. In contrast, fetal rat brain showed relatively high RNR-1 gene expression. These findings suggested that the NGFI-B and RNR-1 genes are differentially expressed in a tissue-specific and developmentally regulated manner.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9023733     DOI: 10.1046/j.1365-2826.1997.00571.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  7 in total

1.  Activation of nerve growth factor-induced B alpha by methylene-substituted diindolylmethanes in bladder cancer cells induces apoptosis and inhibits tumor growth.

Authors:  Sung Dae Cho; Syng-Ook Lee; Sudhakar Chintharlapalli; Maen Abdelrahim; Shaheen Khan; Kyungsil Yoon; Ashish M Kamat; Stephen Safe
Journal:  Mol Pharmacol       Date:  2009-12-18       Impact factor: 4.436

Review 2.  The aetiology of idiopathic Parkinson's disease.

Authors:  D B Ramsden; R B Parsons; S L Ho; R H Waring
Journal:  Mol Pathol       Date:  2001-12

3.  Regulation of Nur77 gene expression by prostanoids in cementoblastic cells.

Authors:  Sanda M Moldovan; Jeanne M Nervina; Sotirios Tetradis; Paulo M Camargo
Journal:  Arch Oral Biol       Date:  2009-02-23       Impact factor: 2.633

4.  TIF1beta/KAP-1 is a coactivator of the orphan nuclear receptor NGFI-B/Nur77.

Authors:  Juliette Rambaud; Julien Desroches; Aurélio Balsalobre; Jacques Drouin
Journal:  J Biol Chem       Date:  2009-03-25       Impact factor: 5.157

5.  Differential regulation of orphan nuclear receptor TR3 transcript variants by novel vascular growth factor signaling pathways.

Authors:  Shengqiang Zhao; Lei Zhou; Gengming Niu; Yan Li; Dezheng Zhao; Huiyan Zeng
Journal:  FASEB J       Date:  2014-07-11       Impact factor: 5.191

6.  Nur77 as a survival factor in tumor necrosis factor signaling.

Authors:  Shinobu Suzuki; Nobutaka Suzuki; Christine Mirtsos; Thomas Horacek; Elizabeth Lye; Seo-Kyu Noh; Alexandra Ho; Denis Bouchard; Tak W Mak; Wen-Chen Yeh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 11.205

7.  Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity.

Authors:  Huiyan Zeng; Liuliang Qin; Dezheng Zhao; Xiaolian Tan; Eleanor J Manseau; Mien Van Hoang; Donald R Senger; Lawrence F Brown; Janice A Nagy; Harold F Dvorak
Journal:  J Exp Med       Date:  2006-03-06       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.